Quest Diagnostics (DGX) Total Liabilities (2009 - 2026)

Quest Diagnostics has disclosed Total Liabilities across 18 years of filings, most recently posting $9.1 billion for Q2 2026.

• In Q2 2026, Total Liabilities rose 4.78% year-over-year to $9.1 billion; the TTM figure through Jun 2026 stood at $9.1 billion (up 4.78% YoY), while the FY2025 annual figure was $9.0 billion, down 3.44% from the prior year.
• Total Liabilities came in at $9.1 billion for Q2 2026 at Quest Diagnostics, up from $9.0 billion in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $9.3 billion in Q4 2024 to a low of $6.7 billion in Q1 2023.
• Average Total Liabilities over 5 years is $8.0 billion, with a median of $7.6 billion recorded in 2023.
• Year-over-year, Total Liabilities slipped 4.57% in 2023 and soared 31.84% in 2024.
• Over 5 years, Total Liabilities stood at $6.9 billion in 2022, then increased by 11.19% to $7.7 billion in 2023, then advanced by 21.61% to $9.3 billion in 2024, then declined by 3.44% to $9.0 billion in 2025, then climbed by 1.12% to $9.1 billion in 2026.
• Per Business Quant data, the three most recent Total Liabilities figures were $9.1 billion in Q2 2026, $9.0 billion in Q1 2026, and $9.0 billion in Q4 2025.